Myriad Genetics Inc (NASDAQ:MYGN)

27.42
Delayed Data
As of Sep 13
 -0.20 / -0.72%
Today’s Change
22.04
Today|||52-Week Range
48.77
-5.68%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues723.1M753.8M771.4M772.6M
 
 
 
 
 
Cost of Goods Sold122.4M130.6M122.9M122.8M
 
 
 
 
 
Depreciation And Amortization25.0M26.7M48.3M54.4M
 
 
 
 
 
 
Operating ExpensesGross Income575.7M596.5M600.2M595.4M
 
 
 
 
 
General Expenses441.5M429.7M516.2M537.9M
 
 
 
 
 
Research And Development75.5M70.6M74.4M70.8M
 
 
 
 
 
Total Operating Expenses588.9M587.0M687.4M715.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income134.2M166.8M84.0M57.5M
 
 
 
 
 
Extraordinary Credit0.000.00800.0K61.2M
 
 
 
Extraordinary Charge0.000.00-38.3M0.00
 
 
Interest Expense On Debt0.000.006.0M3.2M
 
 
 
Other Expenses300.0K1.2M1.2M-400.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income134.9M168.9M42.9M116.9M
 
 
 
 
 
Income Taxes-54.7M-43.6M-21.3M-14.0M
 
 
 
 
 
Minority Interest0.000.00-200.0K-200.0K
 
 
 
Net Income80.2M125.3M21.8M131.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS71.3M70.0M68.3M69.4M
 
 
 
 
 
Shares To Calculate EPS Diluted74.5M73.4M68.8M72.0M
 
 
 
 
 
 
Earnings Per ShareEPS$1.08$1.71$0.32$1.82
 
 
 
 
 
EPS Diluted$1.08$1.71$0.32$1.82